Related Experiment Video
Updated: Aug 1, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Extensive and combined resections in poorly differentiated lung cancer]
Vestnik Khirurgii Imeni I. I. Grekova
|April 1, 1992
Summary
Surgical treatment for poorly differentiated lung cancer may require extended or combined resections. Discrepancies between bronchial biopsy and surgical findings highlight the need for careful preoperative assessment in lung cancer patients.
Area of Science:
- Oncology
- Thoracic Surgery
- Cancer Research
Context:
- Lung cancer treatment
- Low-differentiated lung cancer
- Surgical interventions
Purpose:
- Evaluate surgical treatment outcomes for low-differentiated lung cancer.
- Assess the efficacy of extended and combined resections.
- Analyze discrepancies in preoperative diagnostic methods.
Summary:
- This study reviewed 108 patients with low-differentiated lung cancer.
- Extended and combined lung resections were found to be expedient.
- A significant portion of patients (42.2%) showed differing histological results between bronchial biopsy and operative materials.
- The 5-year survival rate for this group undergoing extended/combined resections was 15.6%.
Impact:
- Informs surgical strategies for challenging lung cancer cases.
- Highlights potential limitations of preoperative biopsy accuracy.
- Contributes to understanding prognostic factors in low-differentiated lung cancer.
